Talkspace (TALK) Competitors $2.76 +0.08 (+2.99%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$2.78 +0.02 (+0.58%) As of 10/24/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TALK vs. PGNY, TDOC, OMDA, AHCO, FTRE, PNTG, PSNL, CDNA, INNV, and FLGTShould you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include Progyny (PGNY), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), Fortrea (FTRE), The Pennant Group (PNTG), Personalis (PSNL), CareDx (CDNA), InnovAge (INNV), and Fulgent Genetics (FLGT). These companies are all part of the "healthcare" industry. Talkspace vs. Its Competitors Progyny Teladoc Health Omada Health AdaptHealth Fortrea The Pennant Group Personalis CareDx InnovAge Fulgent Genetics Talkspace (NASDAQ:TALK) and Progyny (NASDAQ:PGNY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability. Do institutionals & insiders have more ownership in TALK or PGNY? 57.4% of Talkspace shares are held by institutional investors. Comparatively, 94.9% of Progyny shares are held by institutional investors. 23.5% of Talkspace shares are held by insiders. Comparatively, 9.4% of Progyny shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to TALK or PGNY? In the previous week, Progyny had 9 more articles in the media than Talkspace. MarketBeat recorded 13 mentions for Progyny and 4 mentions for Talkspace. Progyny's average media sentiment score of 0.87 beat Talkspace's score of 0.30 indicating that Progyny is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Talkspace 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Progyny 3 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, TALK or PGNY? Progyny has higher revenue and earnings than Talkspace. Progyny is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.46$1.15M$0.02138.00Progyny$1.17B1.44$54.34M$0.5933.03 Do analysts rate TALK or PGNY? Talkspace currently has a consensus target price of $4.50, suggesting a potential upside of 63.04%. Progyny has a consensus target price of $25.44, suggesting a potential upside of 30.55%. Given Talkspace's higher probable upside, analysts clearly believe Talkspace is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 2 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 2.56Progyny 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.70 Which has more risk and volatility, TALK or PGNY? Talkspace has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Is TALK or PGNY more profitable? Progyny has a net margin of 4.28% compared to Talkspace's net margin of 1.41%. Progyny's return on equity of 10.69% beat Talkspace's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace1.41% 2.48% 2.11% Progyny 4.28%10.69%7.12% SummaryProgyny beats Talkspace on 12 of the 17 factors compared between the two stocks. Get Talkspace News Delivered to You Automatically Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TALK vs. The Competition Export to ExcelMetricTalkspaceMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$462.21M$2.26B$6.21B$10.81BDividend YieldN/AN/A5.72%4.80%P/E Ratio138.0740.1731.6030.98Price / Sales2.4611.31595.06133.64Price / Cash232.3060.1937.2561.86Price / Book4.0012.5212.056.61Net Income$1.15M-$64.36M$3.34B$277.10M7 Day PerformanceN/A0.39%1.94%2.57%1 Month Performance-0.72%0.60%6.88%3.20%1 Year Performance-0.72%27.87%56.06%33.22% Talkspace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TALKTalkspace3.2711 of 5 stars$2.76+3.0%$4.50+63.0%-0.7%$462.21M$187.59M138.07500News CoverageUpcoming EarningsAnalyst ForecastPGNYProgyny3.5336 of 5 stars$19.63+1.5%$25.44+29.6%+26.1%$1.66B$1.17B33.27310News CoverageAnalyst ForecastTDOCTeladoc Health1.5107 of 5 stars$8.96+5.0%$9.86+10.1%+10.6%$1.51B$2.57B-7.535,500Trending NewsUpcoming EarningsAnalyst ForecastOptions VolumeGap UpOMDAOmada HealthN/A$25.18+1.1%$25.00-0.7%N/A$1.43BN/A0.00849Analyst ForecastShort Interest ↑AHCOAdaptHealth3.5739 of 5 stars$9.47+3.6%$13.40+41.5%-12.0%$1.24B$3.26B17.5410,500News CoverageAnalyst ForecastFTREFortrea3.305 of 5 stars$10.42+10.3%$12.39+18.9%-34.8%$858.06M$2.70B-0.9215,500Analyst ForecastPNTGThe Pennant Group4.005 of 5 stars$24.00+1.5%$34.40+43.3%-24.7%$817.04M$695.24M30.777,000News CoverageAnalyst ForecastShort Interest ↑PSNLPersonalis2.9067 of 5 stars$10.12+10.8%$7.42-26.7%+105.5%$809.62M$84.61M-7.91400News CoverageAnalyst ForecastHigh Trading VolumeCDNACareDx4.4764 of 5 stars$15.22+5.6%$25.50+67.5%-33.1%$767M$333.79M14.92740News CoverageAnalyst ForecastGap UpINNVInnovAge0.6251 of 5 stars$5.35+0.2%$5.00-6.5%-7.1%$723.63M$853.70M-23.262,440News CoverageAnalyst ForecastGap UpFLGTFulgent Genetics3.7664 of 5 stars$23.84+5.1%$25.33+6.3%+22.2%$694.21M$283.47M-14.361,313News CoverageAnalyst Forecast Related Companies and Tools Related Companies Progyny Competitors Teladoc Health Competitors Omada Health Competitors AdaptHealth Competitors Fortrea Competitors The Pennant Group Competitors Personalis Competitors CareDx Competitors InnovAge Competitors Fulgent Genetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TALK) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredA Worldwide Gold Lockdown Is Now UnderwayCentral banks around the world are hoarding gold at one of the fastest rates in history — and former Goldman S...Stansberry Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis gold stock is STILL undervalued by 80%...“Like buying gold for $1,000/oz” If you could go back in time to 10+ years ago and buy gold for $1,000 an o...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talkspace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talkspace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TALK Stock Alerts